Pivotal Life Sciences Announces the Closing of $389M for Pivotal bioVenture Partners Fund II

SAN FRANCISCO–(BUSINESS WIRE)–Pivotal Life Sciences (the “Firm”), a global investment firm dedicated to investing in companies involved in healthcare innovation seeking to improve patient outcomes, announced today the final close of Pivotal bioVenture Partners Fund II (“Fund II”), with $389 million in capital commitments. Fund II will continue Pivotal bioVenture…
Click here to view original post